 Mass spectrometry can be used to determine whether the protein is light-chain or familial amyloidosis by identifying the protein subunit.Prognosis of cardiac amyloidosis is correlated to the extent of the cardiac dysfunction.Usually the prognosis is not good and aggressive treatments are needed.